Ocular bioavailability of cyclosporine after oral administration
Tabbara, K.F.; Gee, S.S.; Alvarez, H.
Transplantation Proceedings 20(2 Suppl 2: 656-659
1988
ISSN/ISBN: 0041-1345 PMID: 3363663 Document Number: 308709
Document emailed within 1 workday
Related Documents
Wang, X-qing.; Dai, J-dong.; Zhang, Q.; Zhang, T.; Xia, G-min. 2004: Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats Yao Xue Xue Bao 39(6): 463-466Molinaro, M.; Villani, P.; Buggia, I.; Iacona, I.; Zoia, C.; Regazzi, M.B.; Rondanelli, R. 1992: The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations Bollettino Chimico Farmaceutico 131(10): 375-379
Molinaro, M.; Villani, P.; Buggia, I.; Iacona, I.; Zoia, C.; Regazzi, M.B.; Rondanelli, R. 1992: The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations Bollettino Chimico Farmaceutico 131(10): 375-379
Rau, R. 2005: Bioavailability of higher dose MTX comparing oral and subcutaneous administration in patients with RA Journal of Rheumatology 32(7): 1412; Author Reply 1412-3
Cortvriendt, W.R.; Verschoor, J.S.; Hespe, W. 1987: Bioavailability study of a new amoxicillin tablet designed for several modes of oral administration Arzneimittel-Forschung 37(8): 977-979
Venkataramanan, R.; Jain, A.; Warty, V.W.; Abu-Elmagd, K.; Furakawa, H.; Imventarza, O.; Fung, J.; Todo, S.; Starzl, T.E. 1991: Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine Transplantation Proceedings 23(1 Part 2): 931-933
Wetzelsberger, N.; Birkel, M.; Fuder, H.; Lücker, P.W.; Stiegler, S.; Scheithauer, S.; Thümmler, D. 1995: Relative bioavailability of DL-oxyfedrine HCl after single-dose oral administration of tablets as compared to equimolar solutions Methods and Findings in Experimental and Clinical Pharmacology 17(3): 185-191
Degen, J.; Wölke, E.; Seiberling, M.; Thomann, P.; Völter-Erhardt, H. 1997: Comparison of the relative bioavailability and pharmacokinetics of estrone after oral administration of esterified estrogens in a tablet formulation and an aqueous suspension Arzneimittel-Forschung 47(2): 208-212
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20
Van Buren, D.; Wideman, C.A.; Ried, M.; Gibbons, S.; Van Buren, C.T.; Jarowenko, M.; Flechner, S.M.; Frazier, O.H.; Cooley, D.A.; Kahan, B.D. 1984: The antagonistic effect of rifampin upon cyclosporine bioavailability Transplantation Proceedings 16(6): 1642-1645
Borgia, M.; Longo, A.; Lodola, E. 1989: Relative bioavailability of fosfomycin and of trometamol after administration of single dose by oral route of fosfomycin trometamol in fasting conditions and after a meal International Journal of Clinical Pharmacology Therapy and Toxicology 27(8): 411-417
Matera, M.G.; Lampa, E.; Imperatore, A.; Berrino, L.; Russo, F.; Boldrini, E.; Rossi, F. 1998: Bioavailability of timolol and aceclidine after ocular instillation in the rabbit Research Communications in Molecular Pathology and Pharmacology 100(1): 35-42
Schroeder, T.J.; Hariharan, S.; First, M.R. 1995: Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulations Transplantation Proceedings 27(1): 837-839
Jundt, J.W.; Browne, B.A.; Fiocco, G.P.; Steele, A.D.; Mock, D. 1993: A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing Journal of Rheumatology 20(11): 1845-1849
Nussenblatt, R.B. 1988: The use of cyclosporine in ocular inflammatory disorders Transplantation Proceedings 20(3 Suppl 4: 114-121
Winkler, M.; Haller, G.; Oldhafer, K.; Bechstein, W.O.; Kattner, A.; Maibücher, A.; Färber, L.; Ringe, B.; Christians, U.; Neuhaus, P.; Pichlmayr, R. 1996: A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients Transplantation 62(8): 1063-1068
Cooney, G.F.; Alpern, J.B.; Narins, B.E.; Goetz, L.K.; Cavarocchi, N.C. 1989: Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug Clinical Transplants 1989: 324
Vinogradov, V.A.; Kalenikova, E.I.; Sokolov, A.S. 1988: Bioavailability of dalargin and its metabolism during intranasal administration to rats Biulleten' Eksperimental'noi Biologii i Meditsiny 106(7): 48-50
Bergan, T.; Leinebo, O.; Blom-Hagen, T.; Salvesen, B. 1984: Pharmacokinetics and bioavailability of metronidazole after tablets, suppositories and intravenous administration Scandinavian Journal of Gastroenterology. Suppl 91: 45-60
Trenk, D.; Wagner, F.; Jähnchen, E.; Spahn, H.; Mutschler, E. 1987: Pharmacokinetics and bioavailability of piretanide in healthy volunteers following intramuscular administration Arzneimittel-Forschung 37(12): 1382-1385